Kenya - engleză - Pharmacy and Poisons Board

norbrook kenya ltd old limuru road karuri p.o box 1287 00606 nairobi - benzathine penicillin and procaine penicillin - suspension for injection - benzathine penicillin 112.5mg/ml and procaine… - antibacterials for systemic use: other quinolones

Kenya - engleză - Pharmacy and Poisons Board

medisel kenya ltd p.o box 540-01000 thika - benzathine benzylpenicillin bp - 600000 iu… - injection - benzathine benzylpenicillin bp - 600000 iu… - beta-lactamantibacterials: combinations of

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

aspen veterinary resources - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c) - penicillin g 150000 [usp'u] in 1 ml - indications: this product is indicated for the treatment of the following bacterial infections in beef cattle due to penicillin-susceptible microorganisms that are susceptible to the serum levels common to this particular dosage form, such as: 1. bacterial pneumonia (shipping fever complex) (streptococcus spp., actinomyces pyogenes, staphylococcus aureus). 2. upper respiratory infections such as rhinitis or pharyngitis (actinomyces pyogenes). 3. blackleg (clostridium chauvoei).

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

physicians total care, inc. - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c), penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g 600000 [iu] in 2 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin c-r and other antibacterial drugs, bicillin c-r should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is indicated in the treatment of moderately severe infections due to penicillin-g-susceptible microorganisms that are susceptible to serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. bicillin c-r is indicated in the treatment of the following in adults and pediatric patients: moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

dispensing solutions, inc. - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c), penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g 600000 [iu] in 2 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin c-r and other antibacterial drugs, bicillin c-r should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is indicated in the treatment of moderately severe infections due to penicillin-g-susceptible microorganisms that are susceptible to serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. bicillin c-r is indicated in the treatment of the following in adults and pediatric patients: moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

a-s medication solutions - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c) - penicillin g 1200000 [iu] in 2 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin l-a and other antibacterial drugs, bicillin l-a should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. intramuscular penicillin g benzathine is indicated in the treatment of infections due to penicillin-g-sensitive microorganisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular penicillin g benzathine: mild-to-moderate infections of the upper-respiratory tract

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin l-a and other antibacterial drugs, bicillin l-a should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. intramuscular penicillin g benzathine is indicated in the treatment of infections due to penicillin-g-sensitive microorganisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular penicillin g benzathine: mild-to-moderate infections of the upper-respiratory tract due to susceptible streptococci. venereal infections —syphilis, yaws, bejel, and pinta. medical conditions in which penicillin g benzathine therapy is indicated as prophylaxis: rheumatic fever and/or chorea —prophylaxis with penicillin g benzathine has proven effective in preventing recurrence of these conditions. it has also been used as follow-up prophylactic therapy for rheumatic heart disease and acute glomerulonephritis. a history of a previous hypersensitivity reaction to any of the penicillins is a contraindication.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - cephapirin benzathine (unii: 90g868409o) (cephapirin - unii:89b59h32vn) - cephapirin 300 mg in 10 ml - for the treatment of mastitis in dairy cows during the dry period. tomorrow has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows, when caused by streptococcus agalactiae and staphylococcus aureus including penicillin-resistant strains. treatment of the dry cow with tomorrow is indicated in any cow known to harbor any of these organisms in the udder at drying off. indicaciones para el tratamiento de mastitis bovina durante el período seco. extensos estudios clínicos han demostrado que tomorrow es eficaz en el tratamiento de la mastitis en vacas secas, cuando ésta es causada por el streptococcus agalactiae y el staphylococcus aureus, incluyendo cepas resistentes a la penicilina. el tratamiento de la vaca seca con tomorrow es recomendado para cualquier vaca que se sepa alberga a cualquiera de estos organismos en la ubre al momento del período de secado. not for human use. este producto no es para administrarse en humanos.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c), penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g 600000 [iu] in 2 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin c-r and other antibacterial drugs, bicillin c-r should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. this drug is indicated in the treatment of moderately severe infections due to penicillin-g-susceptible microorganisms that are susceptible to serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. bicillin c-r is indicated in the treatment of the following in adults and pediatric patients: moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and skin and soft-tissue infections due to susceptible streptococci. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin g. other groups, including group d (enterococci), are resistant. penicillin g sodium or potassium is recommended for streptococcal infections with bacteremia. moderately severe pneumonia and otitis media due to susceptible streptococcus pneumoniae . note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, peritonitis, and arthritis of pneumococcal etiology are better treated with penicillin g sodium or potassium during the acute stage. when high, sustained serum levels are required, penicillin g sodium or potassium, either im or iv, should be used. this drug should not be used in the treatment of venereal diseases, including syphilis, gonorrhea, yaws, bejel, and pinta. a previous hypersensitivity reaction to any penicillin or to procaine is a contraindication.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - penicillin g benzathine (unii: rit82f58gk) (penicillin g - unii:q42t66vg0c), penicillin g procaine (unii: 17r794esyn) (penicillin g - unii:q42t66vg0c) - penicillin g 900000 [iu] in 2 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bicillin c-r 900/300 and other antibacterial drugs, bicillin c-r 900/300 should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. bicillin c-r 900/300 is indicated in the treatment of infections as described below that are susceptible to serum levels characteristic of this particular dosage form. therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. bicillin c-r 900/300 is indicated in the treatment of the following in pediatric patients: moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and skin and soft-tissue infections due to susceptible streptococci. note: streptococci in groups a, c, g, h, l, and m are very susceptible to penicillin g. other groups, including group d (enterococci), are resistant. penicillin g sodium or potassium is recommended for streptococcal infections with bacteremia. moderately severe pneumonia and otitis media due to susceptible streptococcus pneumoniae . note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, peritonitis, and arthritis of pneumococcal etiology are better treated with penicillin g sodium or potassium during the acute stage. when high, sustained serum levels are required, penicillin g sodium or potassium, either im or iv, should be used. this drug should not be used in the treatment of venereal diseases, including syphilis, gonorrhea, yaws, bejel, and pinta. a previous hypersensitivity reaction to any penicillin or to procaine is a contraindication.